Culture Change At GSK: 'We’re Doing What We Said We’d Do'

R&D Chief Says Doubters Are Coming Round

GSK_HQ
GSK is adopting 'smart risk taking' in R&D • Source: GSK

More from Immuno-oncology

More from Anticancer